495 related articles for article (PubMed ID: 18707827)
1. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.
Gomez DR; Zhung JE; Gomez J; Chan K; Wu AJ; Wolden SL; Pfister DG; Shaha A; Shah JP; Kraus DH; Wong RJ; Lee NY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1096-103. PubMed ID: 18707827
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
4. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.
Sher DJ; Thotakura V; Balboni TA; Norris CM; Haddad RI; Posner MR; Lorch J; Goguen LA; Annino DJ; Tishler RB
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e215-22. PubMed ID: 21531515
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
Pederson AW; Salama JK; Witt ME; Stenson KM; Blair EA; Vokes EE; Haraf DJ
Am J Clin Oncol; 2011 Aug; 34(4):356-61. PubMed ID: 21633289
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy after surgical resection for head and neck mucosal melanoma.
Wu AJ; Gomez J; Zhung JE; Chan K; Gomez DR; Wolden SL; Zelefsky MJ; Wolchok JD; Carvajal RD; Chapman PB; Wong RJ; Shaha AR; Kraus DH; Shah JP; Lee NY
Am J Clin Oncol; 2010 Jun; 33(3):281-5. PubMed ID: 19823070
[TBL] [Abstract][Full Text] [Related]
9. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.
Hoppe BS; Stegman LD; Zelefsky MJ; Rosenzweig KE; Wolden SL; Patel SG; Shah JP; Kraus DH; Lee NY
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):691-702. PubMed ID: 17161557
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
[TBL] [Abstract][Full Text] [Related]
11. Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ
Oral Oncol; 2013 Mar; 49(3):255-60. PubMed ID: 23079695
[TBL] [Abstract][Full Text] [Related]
12. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
[TBL] [Abstract][Full Text] [Related]
13. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced-stage oral cavity cancers.
Lin CY; Wang HM; Kang CJ; Lee LY; Huang SF; Fan KH; Chen EY; Chen IH; Liao CT; Chang JT
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1011-9. PubMed ID: 20434273
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control.
Daly ME; Le QT; Kozak MM; Maxim PG; Murphy JD; Hsu A; Loo BW; Kaplan MJ; Fischbein NJ; Chang DT
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1412-22. PubMed ID: 20675073
[TBL] [Abstract][Full Text] [Related]
18. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
19. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure.
Wiegner EA; Daly ME; Murphy JD; Abelson J; Chapman CH; Chung M; Yu Y; Colevas AD; Kaplan MJ; Fischbein N; Le QT; Chang DT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):243-51. PubMed ID: 22019239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
